Ceva-Phylaxia Expands Monor Presence with New Vaccine Production Unit

Ceva-Phylaxia Expands Monor Presence with New Vaccine Production Unit

2024. 11. 14.

As part of its commitment to expanding its presence in Hungary, global animal vaccine producer Ceva-Phylaxia has announced an EUR 75 million investment, establishing a state-of-the-art unit in Monor dedicated to manufacturing inactivated, multicomponent vaccines. Following the official groundbreaking ceremony for the 7,000-square-meter facility, production is expected to begin by the end of 2026.

France-based Ceva Santé Animale, ranks as the fifth-largest animal health company globally. With a team of skilled veterinarians and experts, Ceva is committed to offering innovative and advanced health solutions that guarantee the highest quality of animal care and welfare. Their portfolio includes a wide range of vaccines, animal welfare products, and pharmaceutical solutions for both livestock and pets.

Ceva has a century-long history in Hungary through Phylaxia, making it a significant player and employer in the country’s animal health industry, with around 1,300 employees across its sites in Budapest and Monor. The company is now strengthening its presence in Hungary with its sixth manufacturing unit, dedicated to the production of animal health vaccines.

The newly established production facility will have the capacity to produce up to 8 billion doses of inactivated, multicomponent vaccines annually. This expansion will also create 120 new jobs in Monor, reinforcing Ceva’s long-term commitment to the Hungarian market.

Sector articles

N
Karsai Holding Zrt.'s Medical and Lab Tech Division Takes Another Leap Forward

The Hungarian medical device manufacturing sector sees further reinforcement through Karsai Alba Ltd.'s latest investment. As part of an EUR 10.86 million project, the fully Hungarian-owned company based in Székesfehérvár has inaugurated a 2,100-square-meter, fu...

2024. 11. 04.

MedTech #MedTech #EUR 10.86 million #Karsai Alba #Székesfehérvár #plastic manufacturing #37 NEW JOBS
N
Schott’s State-of-the-art Prefillable Glass Syringe Plant is now up and Running

By investing EUR 76 million, German-owned Schott Hungary Kft. has now inaugurated its brand-new prefillable syringe facility in Lukácsháza located in Vas county. The project creates 120 new jobs in the area.

2024. 06. 11.

MedTech #MedTech #EUR 76 million #NEW Jobs 120 #Schott #Pre-filled syringes #Lukácsháza
N
Sanofi’s Pre-Filled Syringe Plant To Operate With Expanded Capacity

The latest development at Sanofi's Csanyikvölgy plant was inaugurated at a ceremony, resulting in an investment of almost HUF 8 billion to increase the production capacity of prefilled syringes by one and a half times.

2023. 09. 08.

MedTech #MedTech #Sanofi #Csanyikvölgy #HUF 8 billion #Pre-filled syringes